RECITALSLicense and Marketing Agreement • April 17th, 2007 • Cirtran Corp • Printed circuit boards • Utah
ARGOS TECHNOLOGIES, INC. LICENSE AND MARKETING AGREEMENT ARGOS TECHNOLOGIES, INC., a Delaware Corporation having its principal place of business at 690 Knox Street, Suite 100, Torrance, Ca. 90502, ("LICENSOR") and ARGOS 2000, INC. .a Delaware...License and Marketing Agreement • August 12th, 1998 • Synergy 2000 Inc • California
LICENSE AND MARKETING AGREEMENTLicense and Marketing Agreement • October 16th, 2009 • Zurvita Holdings, Inc. • Metal mining • New York
THIS LICENSE AND MARKETING AGREEMENT ("Agreement”) is entered into as of October 9, 2009 (the "Effective Date") between OmniReliant Holdings, Inc. (“Licensor”) and Zurvita Holdings, Inc (“Licensee”).
EXHIBIT 10.27 Second Amendment to ISV License and Marketing Agreement This Second Amendment, effective December ____, 22, 2000 (the "Second Amendment"), further amends the ISV License and Marketing Agreement dated March 31, 1999, as amended (the...License and Marketing Agreement • March 21st, 2001 • Blue Martini Software Inc • Services-prepackaged software
EXHIBIT 10.19 LICENSE AND MARKETING AGREEMENT BY AND BETWEEN CYTOGEN CORPORATIONLicense and Marketing Agreement • December 19th, 2000 • Advanced Magnetics Inc • In vitro & in vivo diagnostic substances • Massachusetts
THIRD AMENDMENT TO DEVELOPMENT, LICENSE AND MARKETING AGREEMENTLicense and Marketing Agreement • October 23rd, 2003 • Renovis Inc • Pharmaceutical preparations
This Third Amendment (the “Amendment”) to the Development, License and Marketing Agreement dated June 26, 1995, as amended, by and between Centaur Pharmaceuticals, Inc. and Astra AB (the “License Agreement”) is made this 18th day of June, 2002 by and between Centaur Pharmaceuticals, Inc., a Delaware corporation with its principal place of business at 1220 Memorex Drive, Santa Clara CA 95050-2812 (“Centaur”) and AstraZeneca AB, successor to Astra AB, a corporation organized and existing under the laws of Sweden, S-151 85 Sodertalje, Sweden (“AstraZeneca”). Unless otherwise provided, all capitalized terms herein shall have the meaning as set forth in the License Agreement, including any exhibits or amendments thereto.
EXCLUSIVE LICENSE AND MARKETING AGREEMENTLicense and Marketing Agreement • November 9th, 2005 • Depomed Inc • Pharmaceutical preparations • California
This Exclusive License and Marketing Agreement is made and entered into this 21st day of July, 2005, by and between Depomed, Inc. (“Depomed”), a California corporation having an address at 1360 O’Brien Drive, Menlo Park, California 94025, and Esprit Pharma, Inc., (“Esprit”), a Delaware corporation having an address at 2 Tower Center Boulevard, East Brunswick, New Jersey 08816.
SECURITIES AND EXCHANGE COMMISSIONLicense and Marketing Agreement • September 20th, 2018 • Massachusetts
AGREEMENT made as of this 25th day of August 2000 (the "Effective Date), by and between Advanced Magnetics, Inc., a Delaware corporation having an address of 61 Mooney Street, Cambridge, Massachusetts 02138 ("AM"), and Cytogen Corporation, a Delaware corporation, having an address of 600 College Road East, Princeton, New Jersey 08540 ("Cytogen").
CONFIDENTIALLicense and Marketing Agreement • June 14th, 1999 • GHS Inc • Services-computer integrated systems design • California
LICENSE AND MARKETING AGREEMENTLicense and Marketing Agreement • November 24th, 2010 • Green Energy Management Services Holdings, Inc. • Services-management consulting services • Delaware
THIS LICENSE AND MARKETING AGREEMENT ("Agreement") is entered into as of 9-30-10 (the "Effective Date") between GEM RG, Inc. on the one hand (hereafter "Licensee"), and Green RG, Inc., Alfred Meyer and Horn illegible, Inc. on the other (the latter two (2) individuals and one (1) entity are hereafter jointly, severally and in solido, referred to as "Licensors").
LICENSE AND MARKETING AGREEMENT BY AND BETWEEN CELULARITY INC. AND SANUWAVE HEALTH, INC. AUGUST 6, 2020License and Marketing Agreement • August 12th, 2020 • SANUWAVE Health, Inc. • Surgical & medical instruments & apparatus • New York
RECITALLicense and Marketing Agreement • March 31st, 1999 • Esps Inc • New York
EXHIBIT 10.1 CONFIDENTIAL TREATMENT REQUESTED AND CONFIDENTIAL PORTIONS FILED SEPARATELY WITH SEC SOURCE CODE LICENSE AND MARKETING AGREEMENT THIS SOURCE CODE LICENSE AND MARKETING AGREEMENT (this "Agreement"), is entered into as of March 31, 1998, by...License and Marketing Agreement • May 8th, 1998 • Phoenix International LTD Inc • Services-prepackaged software
Technology License and Marketing AgreementLicense and Marketing Agreement • June 14th, 2004 • Teraforce Technology Corp • Communications equipment, nec • North Carolina
This Technology License and Marketing Agreement (this “License Agreement”) is made and entered into as of November 13, 2003 (the “Effective Date”) by and between VISTA Controls, Inc., a California corporation, with offices at 28965 Avenue Penn, Santa Clarita, CA 91355 (“VISTA”), and DNA Computing Solutions, Inc., a Delaware corporation with offices at 1240 East Campbell Road, Richardson, Texas 75081 (“DNA”).
